Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease
2025 · Cell stem cell · 10 citations
https://doi.org/10.1016/j.stem.2025.07.014
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
145
Citations
4
h-index
3
i10-index
Rui Zeng is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Nanoplatforms for cancer theranostics & Nuclear Receptors and Signaling. The author has an h-index of 4, co-authored 12 publications.
https://doi.org/10.1016/j.stem.2025.07.014
https://doi.org/10.1038/s41419-025-08095-w
https://doi.org/10.1021/acsnano.5c14676
Click to start Chat